We evaluated the neutralizing activity in serum from three patients >1 year after recovery from Middle East respiratory syndrome (MERS) associated with mild pneumonia treated with antivirals during the MERS outbreak in South Korea at 2015. The neutralizing activity in serum was measured by pseudovirus inhibition assays. Three-fold diluted serum of subjects showed only 9.7%, 10.3%, and 2.2% reductions in relative light units. So, significant neutralizing activity was not demonstrated in any sera of three patients with mild pneumonia >1 year after being successfully treated with antiviral agents and recovering from MERS coronavirus infection.ope
SummaryThree years after its first discovery in Jeddah Saudi Arabia, the novel zoonotic pathogen of ...
OBJECTIVES The rates of asymptomatic infection with Middle East Respiratory Syndrome (MERS) coronavi...
This study aims to analyze the serum neutralization capacity against Delta and Omicron variants in t...
We investigated the kinetics of the Middle East respiratory syndrome coronavirus (MERS-CoV) neutrali...
Background. Zoonotic coronaviruses have emerged as a global threat by causing fatal respiratory infe...
We investigated the kinetics of the Middle East respiratory syndrome coronavirus (MERS-CoV) neutrali...
BACKGROUND: Evidence points to the emergence of a novel human coronavirus, Middle East respirato...
Background. The Middle East respiratory syndrome (MERS) coronavirus causes isolated cases and outbre...
Middle East Respiratory Syndrome coronavirus (MERS-CoV) causes severe respiratory disease with a hig...
Middle East Respiratory Syndrome coronavirus (MERS-CoV) causes severe pulmonary infection, with ∼35 ...
We investigated the kinetics of severe acute respiratory syndrome coronavirus 2 neutralizing antibod...
We investigated the kinetics of serologic responses to Middle East respiratory syndrome coronavirus ...
We investigated the kinetics of serologic responses to Middle East respiratory syndrome coronavirus ...
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has now been continuing fo...
Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel zoonotic coronavirus that was ide...
SummaryThree years after its first discovery in Jeddah Saudi Arabia, the novel zoonotic pathogen of ...
OBJECTIVES The rates of asymptomatic infection with Middle East Respiratory Syndrome (MERS) coronavi...
This study aims to analyze the serum neutralization capacity against Delta and Omicron variants in t...
We investigated the kinetics of the Middle East respiratory syndrome coronavirus (MERS-CoV) neutrali...
Background. Zoonotic coronaviruses have emerged as a global threat by causing fatal respiratory infe...
We investigated the kinetics of the Middle East respiratory syndrome coronavirus (MERS-CoV) neutrali...
BACKGROUND: Evidence points to the emergence of a novel human coronavirus, Middle East respirato...
Background. The Middle East respiratory syndrome (MERS) coronavirus causes isolated cases and outbre...
Middle East Respiratory Syndrome coronavirus (MERS-CoV) causes severe respiratory disease with a hig...
Middle East Respiratory Syndrome coronavirus (MERS-CoV) causes severe pulmonary infection, with ∼35 ...
We investigated the kinetics of severe acute respiratory syndrome coronavirus 2 neutralizing antibod...
We investigated the kinetics of serologic responses to Middle East respiratory syndrome coronavirus ...
We investigated the kinetics of serologic responses to Middle East respiratory syndrome coronavirus ...
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has now been continuing fo...
Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel zoonotic coronavirus that was ide...
SummaryThree years after its first discovery in Jeddah Saudi Arabia, the novel zoonotic pathogen of ...
OBJECTIVES The rates of asymptomatic infection with Middle East Respiratory Syndrome (MERS) coronavi...
This study aims to analyze the serum neutralization capacity against Delta and Omicron variants in t...